Please provide your email address to receive an email when new articles are posted on . In the PIVOTAL trial, patients undergoing hemodialysis with ferritin concentration less than 400 µg/L and a ...

Patients on hemodialysis who received high-dose had similar rates of infection and rates of hospitalization for infection compared with those treated with low-dose IV iron, a secondary analysis of the ...

Use of erythropoiesis-stimulating agents decreased, while use of iron increased. Meta-analysis reveals no statistically significant increase in the risks of infection, cardiovascular events, ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — The PIVOTAL Trial has shown in patients undergoing hemodialysis, that the use of higher-dose IV iron ...

Until now, no other treatment has been shown to reduce heart attack risk in patients on dialysis. High-dose intravenous (IV) iron reduces the risk for acute myocardial infarction in patients receiving ...

A little over 3 years ago, researchers reported findings from PIVOTAL, the largest prospective, randomized trial to assess an aggressive versus conservative iron-repletion strategy in patients with ...

First and only high-dose intravenous iron for iron deficiency anemia of various etiologies SHIRLEY, N.Y.--(BUSINESS WIRE)--American Regent, Inc., a subsidiary of Luitpold Pharmaceuticals, Inc. (a ...

A new paper in Cardiovascular Research, published by Oxford University Press, indicates that iron treatments may reduce heart attacks in patients experiencing kidney failure undergoing dialysis.

Iron deficiency anemia common but underdiagnosed and undertreated in patients with gastrointestinal conditions; high-dose intravenous iron an effective treatment option CHICAGO--(BUSINESS ...

SAN DIEGO — The proactive use of high-dose intravenous (IV) iron can reduce the amount of erythropoiesis-stimulating agent needed to treat anemia in dialysis patients with no short-term increase in ...